ACM
LEXX icon

ADAR1 Capital Management’s Lexaria Bioscience LEXX Stock Holding History

ADAR1 Capital Management’s Portfolio LEXX Stock Details LEXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-945
Closed -$2.63K – 316
2024
Q2 		$2.63K Sell
945
-25,681
-96% -$77K ﹤0.01% 252
2024
Q1 		$96.7K Buy
26,626
+25,000
+1,538% +$63.7K 0.02% 152
2023
Q4 		$2.03K Buy
+1,626
New +$2.09K ﹤0.01% 156

Other funds holding LEXX

ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
G
GenTrust Miami, Florida $2.34B AUM 18.43% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WG
Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

ADAR1 Capital Management's LEXX Position: Q3 2024 in Review

ADAR1 Capital Management sold out of Lexaria Bioscience (LEXX) in Q3 2024, closing a stake of 945 shares — an estimated $2.63K sold.

ADAR1 Capital Management first reported a position in LEXX in Q4 2023 and held it in 3 quarters. The position peaked at $96.7K in Q1 2024. 27 funds tracked by Wall St. Rank hold LEXX as of Q3 2024.

  • ADAR1 Capital Management reported no remaining Lexaria Bioscience position as of Q3 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 945 Lexaria Bioscience shares in Q3 2024, an estimated $2.63K.
  • ADAR1 Capital Management first reported a position in Lexaria Bioscience in Q4 2023 and held it in 3 quarters.
  • ADAR1 Capital Management's Lexaria Bioscience position peaked at $96.7K in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Lexaria Bioscience as of Q3 2024.

Based on ADAR1 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.